Group Of Experts Looks At High Price Of Cancer Drugs 17/06/2013 by Intellectual Property Watch Leave a Comment Prices of cancer drugs must be lowered to be affordable for patients and to maintain sound long-term healthcare policies, according to a group of chronic myeloid leukemia (CML) experts in a recent Blood journal editorial.
WIPO-WTO-WHO Joint Symposium On Medical Innovation In July 14/06/2013 by Intellectual Property Watch Leave a Comment Three Geneva-based international organisations are continuing their collaboration on issues of health and innovation policy as it cuts across intellectual property rights by planning a 5 July symposium on “changing business models” in medical innovation.
Myriad Case Decided: Natural Human Genes Not Patentable In US 14/06/2013 by Intellectual Property Watch 3 Comments The United States Supreme Court came to a decision yesterday on the case of Association for Molecular Pathology v. Myriad Genetics, Inc., striking down Myriad’s patent on isolating human genes from the bloodstream.
UN Human Rights Council Adopts Resolution Promoting Medicines Access 13/06/2013 by Intellectual Property Watch 1 Comment The United Nations Human Rights Council today adopted a resolution urging governments to encourage technology development and transfer and to apply intellectual property rights measures in ways that avoid creating barriers to trade in “affordable, safe, efficacious and quality medicines.” The resolution includes references to IP flexibilities in international trade law and to “delinkage” of R&D costs with the price of health products.
WHO Updates Guidance For Pandemic Flu Risk Management 13/06/2013 by Intellectual Property Watch 2 Comments The World Health Organization (WHO) has released an updated guidance document on pandemic influenza risk management, which includes the Pandemic Influenza Preparedness (PIP) Framework for the sharing of influenza viruses and access to vaccines and other benefits that was discussed by member states during the 66th World Health Assembly (WHA) in May.
Geneva Study Finds ‘Evergreening’ Increases Healthcare Costs 12/06/2013 by Intellectual Property Watch 2 Comments A recent Geneva-based study found that so-called evergreening practices utilised by drug manufacturers are successful in protecting profits by maintaining company market share and offsetting generic competition and cost containment policies.
Author Cites Persistent Tobacco Industry Attempts To Influence WHO 05/06/2013 by Intellectual Property Watch Leave a Comment Thirteen years after publication of the landmark report, “Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization,” little has changed and industry manipulations continue, one of the lead authors has said.
Data From Clinical Trials Identify Gaps In Health R&D 05/06/2013 by Intellectual Property Watch Leave a Comment Lower-income countries receive much less attention in terms of clinical trial research, according to a study published in this month’s World Health Organization (WHO) Bulletin. The study also underscored the value and importance the WHO International Clinical Trials Registry Platform (ICTRP) provides as a resource for evaluating the distribution of clinical trials around the world, and for providing information for future policy on health R&D.
Report Finds Positives, Weaknesses In US AIDS Relief Programme 31/05/2013 by Brittany Ngo for Intellectual Property Watch Leave a Comment A US report released this week found that the President’s Emergency Plan for AIDS Relief (PEPFAR) has helped to make antiretroviral drug supply chains more efficient and reliable, but still contains several weaknesses that need to be addressed.
Despite Economic Growth, Africa Struggles To Meet All MDGs 28/05/2013 by Intellectual Property Watch Leave a Comment Despite increased economic growth over the past decade, Africa will not reach some of the Millennium Development Goal (MDG) targets set forth in 2000 by the United Nations, including halving poverty by 2015, according to a UN report released yesterday.